Zura Bio Ltd (ZURA): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Zura Bio Ltd (ZURA) following the 2026 Q1 hedge fund 13F filings?

As of today, ZURA has moved -8.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of -12.7%. Since the quarter end (March 31, 2026), ZURA gained -27.6% vs +2.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Zura Bio Ltd (ZURA)

92 + Investors. Track Smart Money conviction in ZURA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ZURA

Based on 92 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added ZURA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

92 hedge funds hold ZURA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +24% more funds vs a year ago

fund count last 6Q

+18 new funds entered over the past year (+24% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 64% buying

63 buying36 selling

Last quarter: 63 funds were net buyers (30 opened a brand new position + 33 added to an existing one). Only 36 were sellers (24 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+8 vs last Q)

new funds entering per quarter

Funds opening a new ZURA position: 20 → 20 → 22 → 30. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 52% entered in last year

■ 24% conviction (2yr+) ■ 24% medium ■ 52% new

Only 22 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +54% but shares only +36% — price-driven

Value

+53%

+35%

Last quarter: the total dollar value of institutional holdings rose +54%, but actual share count only changed +36%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📈

Growing discovery — still being found

9 → 20 → 20 → 22 → 30 new funds/Q

New funds entering each quarter: 20 → 20 → 22 → 30. A growing number of institutions are discovering ZURA each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

📊

Mixed cohorts — 26% veterans, 45% new entrants

■ 26% veterans ■ 28% 1-2yr ■ 45% new

Of 95 current holders: 25 (26%) held 2+ years, 27 held 1–2 years, 43 (45%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

📋

Smaller funds dominant — 8% AUM from top-100

8% from top-100 AUM funds

21 of 92 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.8

out of 10

Moderate Exit Risk

Exit risk score 4.8/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	92	74	24.32%
13F Shares	62M	45M	35.6%
Total Value	$367M	$238M	53.92%
New Positions	30	22	+8
Increased Positions	30	24	+6
Closed Positions	12	14	-2
Reduced Positions	24	19	+5
Total Calls	0	1	-100.0%
Total Puts	3	5	-40.0%
PUT/CALL Ratio	0.0	5.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

24.32%

13F Shares

62M

45M

35.6%

Total Value

$367M

$238M

53.92%

New Positions

Increased Positions

Closed Positions

-2

Reduced Positions

Total Calls

-100.0%

Total Puts

-40.0%

PUT/CALL Ratio

0.0

5.0

Bullish

Institutional Holders (2026 Q1)

92 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ZURA. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ZURA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Pfizer Inc	7.05%	2,838,913	$16.8M
2	Great Point Partners LLC	5.77%	4,215,930	$25.1M
3	KVP Capital Advisors, LP	1.66%	373,128	$2.2M
4	Venrock Adviser, LLC	1.43%	6,434,990	$38.3M
5	Suvretta Capital Management, LLC	1.38%	9,067,001	$53.9M
6	Commodore Capital LP	1.12%	3,250,000	$19.3M
7	Stempoint Capital LP	0.87%	753,520	$4.5M
8	Saturn V Capital Management LP	0.80%	739,960	$4.4M
9	Braidwell LP	0.79%	3,988,989	$23.7M
10	Affinity Asset Advisors, LLC	0.79%	2,564,303	$15.3M
11	Boxer Capital Management, LLC	0.70%	900,000	$5.4M
12	Verdad Advisers, LP	0.65%	97,102	$578K
13	Siren, L.L.C.	0.62%	3,734,866	$22.2M
14	Foresite Capital Management VI LLC	0.58%	450,000	$2.7M
15	Ikarian Capital, LLC	0.58%	1,193,492	$7.1M
16	QVT Financial LP	0.57%	1,310,593	$7.8M
17	Cormorant Asset Management, LP	0.43%	1,450,000	$8.6M
18	Silverarc Capital Management, LLC	0.34%	560,651	$3.3M
19	EcoR1 Capital, LLC	0.30%	1,179,715	$7.0M
20	ADAR1 Capital Management, LLC	0.22%	630,403	$3.8M
21	Armistice Capital, LLC	0.16%	1,507,000	$9.0M
22	Vestal Point Capital, LP	0.09%	511,000	$3.0M
23	Brendel Financial Advisors LLC	0.08%	28,052	$167K
24	Forefront Analytics, LLC	0.08%	14,901	$89K
25	Fox Run Management, L.L.C.	0.05%	46,062	$262K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Zura Bio Ltd (ZURA)

What does the Smart Money Trend signal show for ZURA?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added ZURA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ZURA?

More buyers than sellers — 64% buying: Last quarter: 63 funds were net buyers (30 opened a brand new position + 33 added to an existing one). Only 36 were sellers (24 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ZURA holders?

Smaller funds dominant — 8% AUM from top-100: 21 of 92 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ZURA?

Mostly new holders — 52% entered in last year: Only 22 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Zura Bio Ltd (ZURA) following the 2026 Q1 hedge fund 13F filings?

As of today, ZURA has moved -8.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of -12.7%. Since the quarter end (March 31, 2026), ZURA has gained -27.6% vs +2.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Zura Bio Ltd (ZURA)

Smart Money Signals — ZURA

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +24% more funds vs a year ago

More buyers than sellers — 64% buying

More new buyers each quarter (+8 vs last Q)

Mostly new holders — 52% entered in last year

Value +54% but shares only +36% — price-driven

Growing discovery — still being found

Mixed cohorts — 26% veterans, 45% new entrants

Smaller funds dominant — 8% AUM from top-100

Institutional Sentiment Summary — ZURA

Hedge Fund Ownership: ZURA

Market Analysis: ZURA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ZURA

Is It Too Late to Buy Zura Bio Ltd (ZURA) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: ZURA

Statistics: ZURA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Zura Bio Ltd (ZURA)

Welcome to 13Foresight!